Foghorn Therapeutics Inc. (FHTX)
NASDAQ · Manufacturing · Pharmaceutical preparations
$3.50−$0.1000 (−2.78%) on the dayAs of the close; data may be delayed.
FHTX price, last 12 months
Key stats
- Previous close
- $3.60
- Open
- $3.61
- Day range
- $3.47 – $3.66
- 52-week range
- $3.27 – $7.61
- Volume
- 525.4K
- Avg volume (20 days)
- 449.6K
- Market cap
- $207.8M
Performance
1W−15.5%
1M−47.7%
3M−17.1%
6M−28.6%
YTD−35.2%
1Y−28.7%
vs S&P 500, 1Y−45.5 pts
Technicals and fundamentals
About Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $207.8M